 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/10 mg comp.x 28 | $58.200,89 | (12/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.446,19 |
|
|
|
|
| 160/12.5/5 mg comp.x 28 | $58.759,94 | (12/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.719,42 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $58.759,94 | (12/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.719,42 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $58.759,94 | (12/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.719,42 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $62.141,93 | (12/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $30.372,40 |
|
|
|
|
| |
